12 May 2025 in Archives of Disease in Childhood
Objective Growing evidence suggests that coeliac disease (CeD) is more common in patients with inflammatory bowel disease (IBD) but diagnostic confusion remains due to overlapping histological and clinical features. Few studies have investigated this relationship in children. We aimed to assess the prevalence of CeD in our paediatric IBD cohort and define the characteristics of IBD when CeD coexists. Methods We conducted a retrospective study of all patients <18 years old diagnosed with IBD in Southampton Children’s Hospital between January 2019 and December 2023. Patients were identified using our IBD database, and data were collected on diagnosis, endoscopy, histopathology, serology, IBD treatment and surgery using electronic patient records. Results 18 of the 479 children with IBD were also diagnosed with CeD (3.75%). 14 underwent duodenal biopsy on gluten, with 13 fulfilling Marsh classification 2–3. Eight children had Crohn’s disease, five had ulcerative colitis and five had IBD-unclassified. 16 out of 18 demonstrated colonic disease; 11 out of 18 had pancolitis. There was no significant difference in the rate of biological therapy use between the IBD-CeD and non-coeliac groups (50% vs 68%). No patients with IBD-CeD underwent IBD surgery. Conclusions 1 in 25 children with IBD had coexisting CeD. Pancolitis was the most prominent IBD phenotype but a diagnosis of CeD was not associated with increased escalation to biological therapy, and no patients required surgery. These findings help to describe the paediatric IBD-coeliac phenotype and demonstrate the importance of considering IBD in children with refractory CeD and screening for CeD in children presenting with IBD.
28 October 2025 in Frontline Gastroenterology
Multichannel intraluminal impedance with pH (MII pH) is increasingly used in children and adults for investigating gastro-oesophageal reflux disease and associated symptoms, but the indications in paediatrics are expanding. Adults’ normal values are obtained from healthy volunteers; however, paediatric values are mostly extrapolated and supported by expert consensus. Some aspects of performing and interpreting MII pH are peculiar to paediatric practice, such as the reliance on liquid and purée feed in infants and children with neurodisability, proxy symptom reporting from guardians and the increasing use of MII pH in children with enteral feeding tubes. In these settings, manual analysis with careful inspection of meal time is encouraged. General anaesthesia may impact the validity and quality of the study and clinicians should weigh this risk against the benefit of inserting the catheter under anaesthesia. A preprocedure preparatory discussion to identify any potential child and/or procedure-specific challenges is considered a good practice to improve the technical success.
14 May 2021 in Frontline Gastroenterology
The lipodystrophies are an extremely rare group of metabolic conditions which are categorised based on their pathogenesis and phenotype. While primarily known for the striking loss of subcutaneous adipose tissue which they induce, they may also be associated with significant liver injury. In most cases, this results from the secondary deposition of lipid within hepatic parenchyma and is seen predominantly in generalised lipodystrophy. More rarely, patients may develop autoimmune hepatitis. We report a rare case of a 17-month-old boy who developed features of acquired partial lipodystrophy in association with anti-LKM1-positive autoimmune hepatitis following initial presentation with a Henoch-Schönlein purpura-like illness. We describe his challenging path to diagnosis and discuss his ongoing management in an effort to further our understanding of this rare but significant association. This report highlights the need for close clinical observation and a high index of suspicion for recognising early features of lipodystrophy.